Bone Morphogenetic Proteins Secreted by Breast Cancer Cells Upregulate Bone Sialoprotein Expression in Preosteoblast Cells

It is well established that bone metastases comprise bone; however, the exact factors/mechanisms involved remain unknown. We hypothesized that tumor cells secreted factors capable of altering normal bone metabolism. The aims of the present study were to (1) determine the effects of secretory product...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental cell research 2000-11, Vol.260 (2), p.324-333
Hauptverfasser: Bunyaratavej, Pintippa, Hullinger, Thomas G., Somerman, Martha J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 333
container_issue 2
container_start_page 324
container_title Experimental cell research
container_volume 260
creator Bunyaratavej, Pintippa
Hullinger, Thomas G.
Somerman, Martha J.
description It is well established that bone metastases comprise bone; however, the exact factors/mechanisms involved remain unknown. We hypothesized that tumor cells secreted factors capable of altering normal bone metabolism. The aims of the present study were to (1) determine the effects of secretory products isolated from HT-39 cells, a human breast cancer cell line, on osteoprogenitor cell (MC3T3-E1 cells) behavior, and (2) identify tumor-derived factor(s) that alters osteoblast activities. Conditioned media (CM) from HT-39 cells were collected following a 24-h serum-free culture. The ability of CM to alter gene expression in MC3T3-E1 cells was determined by Northern analysis. CM effects on cell proliferation and mineralization ability were determined using a Coulter counter and von Kossa stain, respectively. MC3T3-E1 cells were treated with CM plus noggin, a factor known to block bone morphogenic proteins (BMPs), to determine whether BMPs, shown to be present in CM, were linked with CM effects on MC3T3-E1 cell activity. In addition, inhibitors of MAP kinase kinase (MEK), protein kinase C (PKC), and protein kinase A were used to identify the intracellular signaling pathway(s) by which the active factors in CM regulated osteoblast behavior. CM treatment significantly enhanced BSP mRNA (2.5-fold over control), but had no effect on cell proliferation. Mineralization assay showed that CM enhanced mineral nodule formation compared to controls. Noggin inhibited CM-induced upregulation of BSP mRNA, suggesting that BMPs were responsible for upregulating BSP gene expression in MC3T3-E1 cells. The PKC inhibitor blocked CM-mediated upregulation of BSP, suggesting involvement of the PKC pathway in regulating BSP expression. BMPs secreted by HT-39 cells may be responsible for enhancing BSP expression in MC3T3-E1 cells. Continued studies targeted at determining the role of BMPs in regulating bone metabolism are important for understanding the pathogenesis of bone diseases.
doi_str_mv 10.1006/excr.2000.5019
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72346358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014482700950195</els_id><sourcerecordid>72346358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-db01061922361eb460159b8a1118efb2bdffc70ecc8b482acaabf872fab1d7ca3</originalsourceid><addsrcrecordid>eNp1kEFP3DAQRq2qqCy01x4rn3rLMuNkE-dYVrQggVhp4WzZzoS6ysZb24uAX4_DrsSJkzXy-z7NPMa-I8wRoD6jJxvmAgDmC8D2E5shtFCISojPbAaAVVFJ0Ryzkxj_ZUpKrL-wY0QoF61oZuzl3I_Eb3zY_vUPNFJylq-CT-TGyNdkAyXquHnm54F0THypR0uBL2kYIr_fBnrYDToRf6tZOz347T7NL57yb4zOjzxPq0A-JvJmeGuZ4l_ZUa-HSN8O7ym7_31xt7wsrm__XC1_XRe2rCAVnQGEGlshyhrJVDXgojVSI6Kk3gjT9b1tgKyVJt-qrdaml43otcGusbo8ZT_3vXmz_zuKSW1ctHkDPZLfRdWIsqrLhczgfA_a4GMM1KttcBsdnhWCmmyrybaabKvJdg78ODTvzIa6d_ygNwNyD1C-79FRUNE6ygY7F8gm1Xn3UfcrYtORQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72346358</pqid></control><display><type>article</type><title>Bone Morphogenetic Proteins Secreted by Breast Cancer Cells Upregulate Bone Sialoprotein Expression in Preosteoblast Cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Bunyaratavej, Pintippa ; Hullinger, Thomas G. ; Somerman, Martha J.</creator><creatorcontrib>Bunyaratavej, Pintippa ; Hullinger, Thomas G. ; Somerman, Martha J.</creatorcontrib><description>It is well established that bone metastases comprise bone; however, the exact factors/mechanisms involved remain unknown. We hypothesized that tumor cells secreted factors capable of altering normal bone metabolism. The aims of the present study were to (1) determine the effects of secretory products isolated from HT-39 cells, a human breast cancer cell line, on osteoprogenitor cell (MC3T3-E1 cells) behavior, and (2) identify tumor-derived factor(s) that alters osteoblast activities. Conditioned media (CM) from HT-39 cells were collected following a 24-h serum-free culture. The ability of CM to alter gene expression in MC3T3-E1 cells was determined by Northern analysis. CM effects on cell proliferation and mineralization ability were determined using a Coulter counter and von Kossa stain, respectively. MC3T3-E1 cells were treated with CM plus noggin, a factor known to block bone morphogenic proteins (BMPs), to determine whether BMPs, shown to be present in CM, were linked with CM effects on MC3T3-E1 cell activity. In addition, inhibitors of MAP kinase kinase (MEK), protein kinase C (PKC), and protein kinase A were used to identify the intracellular signaling pathway(s) by which the active factors in CM regulated osteoblast behavior. CM treatment significantly enhanced BSP mRNA (2.5-fold over control), but had no effect on cell proliferation. Mineralization assay showed that CM enhanced mineral nodule formation compared to controls. Noggin inhibited CM-induced upregulation of BSP mRNA, suggesting that BMPs were responsible for upregulating BSP gene expression in MC3T3-E1 cells. The PKC inhibitor blocked CM-mediated upregulation of BSP, suggesting involvement of the PKC pathway in regulating BSP expression. BMPs secreted by HT-39 cells may be responsible for enhancing BSP expression in MC3T3-E1 cells. Continued studies targeted at determining the role of BMPs in regulating bone metabolism are important for understanding the pathogenesis of bone diseases.</description><identifier>ISSN: 0014-4827</identifier><identifier>EISSN: 1090-2422</identifier><identifier>DOI: 10.1006/excr.2000.5019</identifier><identifier>PMID: 11035927</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>3T3 Cells ; Animals ; Bone and Bones - metabolism ; Bone Morphogenetic Protein 2 ; Bone Morphogenetic Protein 4 ; Bone Morphogenetic Protein 7 ; bone morphogenetic proteins ; Bone Morphogenetic Proteins - antagonists &amp; inhibitors ; Bone Morphogenetic Proteins - genetics ; Bone Morphogenetic Proteins - metabolism ; Bone Morphogenetic Proteins - pharmacology ; bone sialoprotein ; breast cancer ; Breast Neoplasms - metabolism ; Carrier Proteins ; Cell Differentiation ; Culture Media, Conditioned ; Female ; Humans ; Mice ; osteoblasts ; Osteoblasts - cytology ; Osteoblasts - metabolism ; Proteins - metabolism ; Proteins - pharmacology ; RNA, Messenger ; Sialoglycoproteins - genetics ; Stem Cells ; Temperature ; Transforming Growth Factor beta ; Trypsin ; Tumor Cells, Cultured ; Up-Regulation - drug effects</subject><ispartof>Experimental cell research, 2000-11, Vol.260 (2), p.324-333</ispartof><rights>2000 Academic Press</rights><rights>Copyright 2000 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-db01061922361eb460159b8a1118efb2bdffc70ecc8b482acaabf872fab1d7ca3</citedby><cites>FETCH-LOGICAL-c340t-db01061922361eb460159b8a1118efb2bdffc70ecc8b482acaabf872fab1d7ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014482700950195$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11035927$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bunyaratavej, Pintippa</creatorcontrib><creatorcontrib>Hullinger, Thomas G.</creatorcontrib><creatorcontrib>Somerman, Martha J.</creatorcontrib><title>Bone Morphogenetic Proteins Secreted by Breast Cancer Cells Upregulate Bone Sialoprotein Expression in Preosteoblast Cells</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>It is well established that bone metastases comprise bone; however, the exact factors/mechanisms involved remain unknown. We hypothesized that tumor cells secreted factors capable of altering normal bone metabolism. The aims of the present study were to (1) determine the effects of secretory products isolated from HT-39 cells, a human breast cancer cell line, on osteoprogenitor cell (MC3T3-E1 cells) behavior, and (2) identify tumor-derived factor(s) that alters osteoblast activities. Conditioned media (CM) from HT-39 cells were collected following a 24-h serum-free culture. The ability of CM to alter gene expression in MC3T3-E1 cells was determined by Northern analysis. CM effects on cell proliferation and mineralization ability were determined using a Coulter counter and von Kossa stain, respectively. MC3T3-E1 cells were treated with CM plus noggin, a factor known to block bone morphogenic proteins (BMPs), to determine whether BMPs, shown to be present in CM, were linked with CM effects on MC3T3-E1 cell activity. In addition, inhibitors of MAP kinase kinase (MEK), protein kinase C (PKC), and protein kinase A were used to identify the intracellular signaling pathway(s) by which the active factors in CM regulated osteoblast behavior. CM treatment significantly enhanced BSP mRNA (2.5-fold over control), but had no effect on cell proliferation. Mineralization assay showed that CM enhanced mineral nodule formation compared to controls. Noggin inhibited CM-induced upregulation of BSP mRNA, suggesting that BMPs were responsible for upregulating BSP gene expression in MC3T3-E1 cells. The PKC inhibitor blocked CM-mediated upregulation of BSP, suggesting involvement of the PKC pathway in regulating BSP expression. BMPs secreted by HT-39 cells may be responsible for enhancing BSP expression in MC3T3-E1 cells. Continued studies targeted at determining the role of BMPs in regulating bone metabolism are important for understanding the pathogenesis of bone diseases.</description><subject>3T3 Cells</subject><subject>Animals</subject><subject>Bone and Bones - metabolism</subject><subject>Bone Morphogenetic Protein 2</subject><subject>Bone Morphogenetic Protein 4</subject><subject>Bone Morphogenetic Protein 7</subject><subject>bone morphogenetic proteins</subject><subject>Bone Morphogenetic Proteins - antagonists &amp; inhibitors</subject><subject>Bone Morphogenetic Proteins - genetics</subject><subject>Bone Morphogenetic Proteins - metabolism</subject><subject>Bone Morphogenetic Proteins - pharmacology</subject><subject>bone sialoprotein</subject><subject>breast cancer</subject><subject>Breast Neoplasms - metabolism</subject><subject>Carrier Proteins</subject><subject>Cell Differentiation</subject><subject>Culture Media, Conditioned</subject><subject>Female</subject><subject>Humans</subject><subject>Mice</subject><subject>osteoblasts</subject><subject>Osteoblasts - cytology</subject><subject>Osteoblasts - metabolism</subject><subject>Proteins - metabolism</subject><subject>Proteins - pharmacology</subject><subject>RNA, Messenger</subject><subject>Sialoglycoproteins - genetics</subject><subject>Stem Cells</subject><subject>Temperature</subject><subject>Transforming Growth Factor beta</subject><subject>Trypsin</subject><subject>Tumor Cells, Cultured</subject><subject>Up-Regulation - drug effects</subject><issn>0014-4827</issn><issn>1090-2422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFP3DAQRq2qqCy01x4rn3rLMuNkE-dYVrQggVhp4WzZzoS6ysZb24uAX4_DrsSJkzXy-z7NPMa-I8wRoD6jJxvmAgDmC8D2E5shtFCISojPbAaAVVFJ0Ryzkxj_ZUpKrL-wY0QoF61oZuzl3I_Eb3zY_vUPNFJylq-CT-TGyNdkAyXquHnm54F0THypR0uBL2kYIr_fBnrYDToRf6tZOz347T7NL57yb4zOjzxPq0A-JvJmeGuZ4l_ZUa-HSN8O7ym7_31xt7wsrm__XC1_XRe2rCAVnQGEGlshyhrJVDXgojVSI6Kk3gjT9b1tgKyVJt-qrdaml43otcGusbo8ZT_3vXmz_zuKSW1ctHkDPZLfRdWIsqrLhczgfA_a4GMM1KttcBsdnhWCmmyrybaabKvJdg78ODTvzIa6d_ygNwNyD1C-79FRUNE6ygY7F8gm1Xn3UfcrYtORQw</recordid><startdate>20001101</startdate><enddate>20001101</enddate><creator>Bunyaratavej, Pintippa</creator><creator>Hullinger, Thomas G.</creator><creator>Somerman, Martha J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001101</creationdate><title>Bone Morphogenetic Proteins Secreted by Breast Cancer Cells Upregulate Bone Sialoprotein Expression in Preosteoblast Cells</title><author>Bunyaratavej, Pintippa ; Hullinger, Thomas G. ; Somerman, Martha J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-db01061922361eb460159b8a1118efb2bdffc70ecc8b482acaabf872fab1d7ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>3T3 Cells</topic><topic>Animals</topic><topic>Bone and Bones - metabolism</topic><topic>Bone Morphogenetic Protein 2</topic><topic>Bone Morphogenetic Protein 4</topic><topic>Bone Morphogenetic Protein 7</topic><topic>bone morphogenetic proteins</topic><topic>Bone Morphogenetic Proteins - antagonists &amp; inhibitors</topic><topic>Bone Morphogenetic Proteins - genetics</topic><topic>Bone Morphogenetic Proteins - metabolism</topic><topic>Bone Morphogenetic Proteins - pharmacology</topic><topic>bone sialoprotein</topic><topic>breast cancer</topic><topic>Breast Neoplasms - metabolism</topic><topic>Carrier Proteins</topic><topic>Cell Differentiation</topic><topic>Culture Media, Conditioned</topic><topic>Female</topic><topic>Humans</topic><topic>Mice</topic><topic>osteoblasts</topic><topic>Osteoblasts - cytology</topic><topic>Osteoblasts - metabolism</topic><topic>Proteins - metabolism</topic><topic>Proteins - pharmacology</topic><topic>RNA, Messenger</topic><topic>Sialoglycoproteins - genetics</topic><topic>Stem Cells</topic><topic>Temperature</topic><topic>Transforming Growth Factor beta</topic><topic>Trypsin</topic><topic>Tumor Cells, Cultured</topic><topic>Up-Regulation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bunyaratavej, Pintippa</creatorcontrib><creatorcontrib>Hullinger, Thomas G.</creatorcontrib><creatorcontrib>Somerman, Martha J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bunyaratavej, Pintippa</au><au>Hullinger, Thomas G.</au><au>Somerman, Martha J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bone Morphogenetic Proteins Secreted by Breast Cancer Cells Upregulate Bone Sialoprotein Expression in Preosteoblast Cells</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>2000-11-01</date><risdate>2000</risdate><volume>260</volume><issue>2</issue><spage>324</spage><epage>333</epage><pages>324-333</pages><issn>0014-4827</issn><eissn>1090-2422</eissn><abstract>It is well established that bone metastases comprise bone; however, the exact factors/mechanisms involved remain unknown. We hypothesized that tumor cells secreted factors capable of altering normal bone metabolism. The aims of the present study were to (1) determine the effects of secretory products isolated from HT-39 cells, a human breast cancer cell line, on osteoprogenitor cell (MC3T3-E1 cells) behavior, and (2) identify tumor-derived factor(s) that alters osteoblast activities. Conditioned media (CM) from HT-39 cells were collected following a 24-h serum-free culture. The ability of CM to alter gene expression in MC3T3-E1 cells was determined by Northern analysis. CM effects on cell proliferation and mineralization ability were determined using a Coulter counter and von Kossa stain, respectively. MC3T3-E1 cells were treated with CM plus noggin, a factor known to block bone morphogenic proteins (BMPs), to determine whether BMPs, shown to be present in CM, were linked with CM effects on MC3T3-E1 cell activity. In addition, inhibitors of MAP kinase kinase (MEK), protein kinase C (PKC), and protein kinase A were used to identify the intracellular signaling pathway(s) by which the active factors in CM regulated osteoblast behavior. CM treatment significantly enhanced BSP mRNA (2.5-fold over control), but had no effect on cell proliferation. Mineralization assay showed that CM enhanced mineral nodule formation compared to controls. Noggin inhibited CM-induced upregulation of BSP mRNA, suggesting that BMPs were responsible for upregulating BSP gene expression in MC3T3-E1 cells. The PKC inhibitor blocked CM-mediated upregulation of BSP, suggesting involvement of the PKC pathway in regulating BSP expression. BMPs secreted by HT-39 cells may be responsible for enhancing BSP expression in MC3T3-E1 cells. Continued studies targeted at determining the role of BMPs in regulating bone metabolism are important for understanding the pathogenesis of bone diseases.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11035927</pmid><doi>10.1006/excr.2000.5019</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4827
ispartof Experimental cell research, 2000-11, Vol.260 (2), p.324-333
issn 0014-4827
1090-2422
language eng
recordid cdi_proquest_miscellaneous_72346358
source MEDLINE; Elsevier ScienceDirect Journals
subjects 3T3 Cells
Animals
Bone and Bones - metabolism
Bone Morphogenetic Protein 2
Bone Morphogenetic Protein 4
Bone Morphogenetic Protein 7
bone morphogenetic proteins
Bone Morphogenetic Proteins - antagonists & inhibitors
Bone Morphogenetic Proteins - genetics
Bone Morphogenetic Proteins - metabolism
Bone Morphogenetic Proteins - pharmacology
bone sialoprotein
breast cancer
Breast Neoplasms - metabolism
Carrier Proteins
Cell Differentiation
Culture Media, Conditioned
Female
Humans
Mice
osteoblasts
Osteoblasts - cytology
Osteoblasts - metabolism
Proteins - metabolism
Proteins - pharmacology
RNA, Messenger
Sialoglycoproteins - genetics
Stem Cells
Temperature
Transforming Growth Factor beta
Trypsin
Tumor Cells, Cultured
Up-Regulation - drug effects
title Bone Morphogenetic Proteins Secreted by Breast Cancer Cells Upregulate Bone Sialoprotein Expression in Preosteoblast Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A55%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bone%20Morphogenetic%20Proteins%20Secreted%20by%20Breast%20Cancer%20Cells%20Upregulate%20Bone%20Sialoprotein%20Expression%20in%20Preosteoblast%20Cells&rft.jtitle=Experimental%20cell%20research&rft.au=Bunyaratavej,%20Pintippa&rft.date=2000-11-01&rft.volume=260&rft.issue=2&rft.spage=324&rft.epage=333&rft.pages=324-333&rft.issn=0014-4827&rft.eissn=1090-2422&rft_id=info:doi/10.1006/excr.2000.5019&rft_dat=%3Cproquest_cross%3E72346358%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72346358&rft_id=info:pmid/11035927&rft_els_id=S0014482700950195&rfr_iscdi=true